Hidden Nuclear Role of Metabolic Enzyme FAH Drives Breast Cancer Drug Resistance
Boston Children's Hospital researchers discovered that the metabolic enzyme FAH moves into the nucleus of breast cancer cells and drives ...
Boston Children's Hospital researchers discovered that the metabolic enzyme FAH moves into the nucleus of breast cancer cells and drives ...
Three commercially approved metabolism-targeting drugs—pioglitazone, melatonin and insulin—improved survival, motor function, muscle size and hepatic pathology in Smn2B/- spinal muscular ...
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
A Swedish prospective study shows that the hyperemic zone surrounding microwave-ablated liver tumors is arterially supplied and peaks in intensity ...
Researchers report that combining host-directed and direct-acting antivirals yields synergistic inhibition across alpha, beta, and gamma herpesviruses in cell culture ...
A new case report and scoping review describe a treatment-resistant psoriatic arthritis patient who achieved complete symptom resolution after adding ...
A Phase IV trial in India found that a once-daily metoprolol-telmisartan fixed-dose combination significantly lowered 24-hour blood pressure in patients ...
Researchers at the University of Qom have developed BT-Synergy, a hybrid BiLSTM-Transformer deep learning model that predicts synergistic cancer drug ...
A new Molecular Cancer review proposes immune-pressure redistribution as a unifying framework explaining why patients resist PD-1/PD-L1 blockade and how ...
First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine